Overview

Effect of Androgel on Type 2 Diabetic Males With Hypogonadism

Status:
Unknown status
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
This is to study the effect of replacing testosterone on different inflammatory cells in type 2 diabetics with low testosterone levels.
Phase:
Phase 4
Details
Lead Sponsor:
Kaleida Health
Collaborator:
Solvay Pharmaceuticals
Treatments:
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate